Effect of phenazine methosulfate on electrophysiological activity of the semicircular canal: antioxidant properties of trimetazidine.
Ischemia strokes appear to be the main source of cochleo-vestibular dysfunctions of peripheral origin. The present study aimed to investigate the action of oxygen free radicals on the bioelectric activity of the labyrinthine epithelium, using the frog semicircular canal as an in vitro preparation. We also examined the possible effect of the antianginal drug, trimetazidine (TMZ), under physiological conditions and during the administration of phenazine methosulfate (PMS). The model allows the ionic composition of endolymphatic and perilymphatic fluids bathing the semicircular canal to be dealt with separately. Spontaneous afferent vestibular nerve activity and the endolymphatic potential were recorded under resting conditions. Three additional parameters were investigated during mechanical displacement of the endolymphatic fluid: the ampullar direct current, the nerve direct current and the frequency of the evoked afferent spikes. Addition of TMZ (10(-6) and 10(-5) M, 50 min) into the perilymphatic compartment did not induce significant modifications of the different bioelectrical signals. Generation of oxygen free radicals, through administration of PMS (10(-5) M, 15 min) into the perilymphatic compartment, caused an impairment of all bioelectrical signals, except the ampullar direct current. The spontaneous activity, nerve direct current and frequency of afferent evoked spikes signals were significantly reduced 75 min after the start of PMS administration (-64, -17 and -32%, respectively). In contrast, there was a marked increase of the endolymphatic potential signal (+51%). Addition of TMZ (10(-6) or 10(-5) M) into the perilymph solution reversed the effect of PMS on all bioelectrical signals. These results indicate that TMZ acts as an antioxidant molecule which is capable of protecting the labyrinthine epithelium from the deleterious effect of oxygen radicals. Our data suggest that the protective effect of TMZ on ischemia-induced cochleo-vestibular dysfunctions may be accounted for by the antioxidant properties of this antianginal drug.
Aubert
A
A
CNRS URA 650, Unité Affiliée INSERM, Université de Rouen, Mont-Saint-Aignan, France.
Bernard
C
C
Clauser
P
P
Harpey
C
C
Vaudry
H
H
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D004594:Electrophysiology; D005071:Evoked Potentials / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008297:Male; D008773:Methylphenazonium Methosulfate / Q000494:pharmacology*; D009475:Neurons, Afferent / Q000187:drug effects; D010619:Phenazines / Q000494:pharmacology*; D010812:Physical Stimulation; D010879:Piperazines / Q000494:pharmacology*; D011895:Rana ridibunda; D012665:Semicircular Canals / Q000187:drug effects*; D014292:Trimetazidine / Q000494:pharmacology*
D000975:Antioxidants; D010619:Phenazines; D010879:Piperazines; D008773:Methylphenazonium Methosulfate; D014292:Trimetazidine